Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENTRANCE exploratory HIV reservoir study
NL-OMON59143Phase 1Active, not recruiting
- Sponsor
- ViiV Healthcare
- Start
- Dec 2025
- Modality
- Anti-infectious Disease mAbs → Neutralizing Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics, Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1 trial of VH3810109 in human immunodeficiency virus infection (HIV) (2 arms), sponsored by ViiV Healthcare. Started Dec 2025; status: active, not recruiting.
02
Drugs
VH3810109
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON59143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59143.